Kenneth Bradstock
Professor
Medicine
University of Sydney
Australia
Biography
Professor Bradstock is a clinical hematologist at Westmead Hospital with research interests in the treatment of hematological malignancies, and a focus on allogeneic bone marrow transplantation. He is involved in numerous clinical trials in leukemia and lymphoma, and has an active interest in developing new therapeutics for the treatment of acute lymphoblastic leukemia. He is also a member of the Dendritic Cell Biology and Therapeutics Group at the Anzac Research Institute, and, with Professor Derek Hart, is involved in developing new approaches for treatment of graft-versus-host disease based on a better understanding of the role of dendritic cells in this disease.
Research Interest
Medicine
Publications
-
Fromm, P., Papadimitrious, M., Hsu, J., Van Kooten Losio, N., Verma, N., Lo, T., Silveira, P., Bryant, C., Turtle, C., Prue, R., Horvath, L., Bradstock, K., Joshua, D., Clark, G., Hart, D., et al (2016). CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses. OncoImmunology, 5(6), 1-12.
-
Bryant, C., Fromm, P., Kupresanin, F., Clark, G., Lee, K., Clarke, C., Silveira, P., Suen, H., Brown, R., Newman, E., Ho, J., Bradstock, K., Joshua, D., Hart, D., et al (2016). A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset. Immunology and Cell Biology, 94(5), 447-457.
-
Paul, C., Hall, A., Oldmeadow, C., Lynagh, M., Campbell, S., Bradstock, K., Williamson, A., Carey, M., Sanson-Fisher, R. (2017). Dyadic interdependence of psychosocial outcomes among haematological cancer survivors and their support persons. Supportive Care in Cancer, In Press, 1-8.
